Indiana University and IUPUI faculty, students and alumni will be in the spotlight at a Bloomington event for entrepreneurs, venture capitalists, developers, community leaders, creatives and techies. The Combine is an annual conference that connects innovators across the Midwest. More than 1,500 people have attended the conference, which was established in 2010. The 2018 conference… Read more »
Technology Commercialization
Apexian Pharmaceuticals closes Series A funding round
Congratulations to Apexian Pharmaceuticals, which licenses technology through the Indiana University Innovation and Commercialization Office. Mark R. Kelley, Apexian Pharmaceuticals’ chief scientific officer, is the Betty and Earl Herr Chair in Pediatric Oncology Research and a professor in the Department of Biochemistry and Molecular Biology and the Department of Pharmacology and Toxicology at the Indiana University… Read more »
These 58 IU researchers were named on issued patents in 2016-17
Indiana University had a strong year in technology transfer activity in 2016-17, reporting a 10-year high in licensing agreements and a year-over-year increase in invention disclosures. Also, the U.S. Patent and Trademark Office issued a record 57 patents on IU discoveries in 2016-17, eclipsing the previous record of 53 issued the year before. Another 142… Read more »
IUPUI researcher to promote high-tech device during Indianapolis forum Oct. 27
M. Terry Loghmani, associate professor of physical therapy in the Indiana University School of Health and Rehabilitation Sciences, will speak about a medical device system developed at IUPUI during an event today, Oct. 27. The Invention to Startup Forum is scheduled for 12:30-1:30 p.m. at the Indiana Center for Biomedical Innovation, 1800 N. Capitol Ave., in… Read more »
Apexian Pharmaceuticals selected for NCI SBIR Investor Initiatives program
Congratulations to Indianapolis-based Apexian Pharmaceuticals, a clinical-stage biotech company developing novel compounds to treat cancer by leveraging intellectual property discovered at the Indiana University School of Medicine. The company has been selected to participate in the National Cancer Institute’s SBIR Investor Initiatives program. As part of the program, Dr. Richard Messmann — Apexian’s chief medical… Read more »
IU travels to Washington, D.C., to present Naval Surface Warfare Center, Crane Division’s impact on Midwest innovation
On Sept. 27, leaders from Naval Surface Warfare Center, Crane Division and other Indiana industry and academic partners traveled to Washington, D.C. They briefed representatives from the Office of the Vice President of the United States and the Office of Science and Technology Policy on the innovation ecosystem NSWC Crane has helped develop in Southern… Read more »
State business, academic and community leaders establish Applied Research Institute to generate tech transfer, commercialization activity
A new organization has been established by leaders in Indiana government, research universities, industry, and the largest military asset to generate technology transfer and commercialization in military defense and other sectors of the state’s economy. The Applied Research Institute provides streamlined access to more than $1 billion in state-of-the-art laboratories, equipment and research facilities across… Read more »
Director of the IU Innovation and Commercialization Office to promote university’s startup program on webinar
University leaders developing programs to encourage faculty entrepreneurship and startup creation, which can strengthen economic development in a region or state as inventions are developed and taken to market, will learn about one of the best programs in the country during a webinar next week. Dave Wilhite, director of the IU Innovation and Commercialization Office,… Read more »
Congratulations to Chondrial Therapeutics, which licenses Indiana University IP
Chondrial Therapeutics Inc. has been granted orphan drug status by the U.S. Food and Drug Administration for CTI-1601, its drug candidate to treat Friedreich’s ataxia. The Pennsylvania-based biotechnology company licenses intellectual property developed at the Indiana University School of Medicine. This IP was invented by Dr. R. Mark Payne, professor of pediatric cardiology at the… Read more »
IU School of Medicine researchers disclose more than 70 inventions in the 2016-17 fiscal year
Faculty, staff and student researchers at the Indiana University School of Medicine reported 73 inventions during the fiscal year July 1, 2016, to June 30, 2017. Over the last two fiscal years, IU School of Medicine researchers disclosed 147 inventions. Disclosures were made to Indiana University Research and Technology Corp., which served to protect, market… Read more »